Wellvone



Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 41.7%
Cerebral Toxoplasmosis 10.6%
Drug Use For Unknown Indication 7.6%
Hiv Infection 7.6%
Rheumatoid Arthritis 3.8%
Pneumocystis Jiroveci Pneumonia 3.0%
Pneumocystis Jirovecii Pneumonia 3.0%
Tuberculosis 3.0%
Hypertension 2.3%
Oligodendroglioma 2.3%
Pneumonia Herpes Viral 2.3%
Asthma 1.5%
Disseminated Tuberculosis 1.5%
Extrapulmonary Tuberculosis 1.5%
Herpes Simplex 1.5%
Pneumocystis Jiroveci Infection 1.5%
Pneumocystis Jirovecii Infection 1.5%
Prophylaxis 1.5%
Prophylaxis Against Transplant Rejection 1.5%
Antibiotic Prophylaxis 0.8%
Leukopenia 10.3%
Toxic Epidermal Necrolysis 10.3%
Gamma-glutamyltransferase Increased 6.9%
Hepatic Failure 6.9%
Rash Maculo-papular 6.9%
Renal Failure Acute 6.9%
Ventricular Arrhythmia 6.9%
Agranulocytosis 3.4%
Anaemia 3.4%
Cytolytic Hepatitis 3.4%
Eosinophil Count Increased 3.4%
Febrile Neutropenia 3.4%
Hyperbilirubinaemia 3.4%
Lactic Acidosis 3.4%
Neutropenia 3.4%
No Adverse Drug Reaction 3.4%
Off Label Use 3.4%
Pancytopenia 3.4%
Pneumocystis Jiroveci Pneumonia 3.4%
Pneumocystis Jirovecii Infection 3.4%
Secondary
Product Used For Unknown Indication 27.5%
Hiv Infection 11.9%
Hiv Test Positive 11.0%
Drug Use For Unknown Indication 7.3%
Prophylaxis 4.6%
Prophylactic Chemotherapy 3.7%
Tuberculosis 3.7%
Acute Lymphocytic Leukaemia 2.8%
Central Nervous System Lymphoma 2.8%
Cryptococcosis 2.8%
Epilepsy 2.8%
Lymphoma 2.8%
Pneumocystis Jiroveci Pneumonia 2.8%
Pneumocystis Jirovecii Pneumonia 2.8%
Staphylococcal Bacteraemia 2.8%
Cytomegalovirus Infection 1.8%
Hepatitis C 1.8%
Hepatitis Cholestatic 1.8%
Pneumonia 1.8%
Anxiety 0.9%
Thrombocytopenia 22.2%
Toxic Epidermal Necrolysis 14.8%
Vomiting 14.8%
Pyrexia 7.4%
Anaemia Macrocytic 3.7%
Cytolytic Hepatitis 3.7%
Lobar Pneumonia 3.7%
Pneumocystis Jirovecii Infection 3.7%
Rash Maculo-papular 3.7%
Rash Pruritic 3.7%
Tachycardia 3.7%
Toxic Skin Eruption 3.7%
Transaminases Increased 3.7%
Urticaria 3.7%
Ventricular Arrhythmia 3.7%
Concomitant
Product Used For Unknown Indication 23.0%
Hiv Infection 22.5%
Drug Use For Unknown Indication 15.1%
Hodgkin's Disease 5.7%
Acute Myeloid Leukaemia 3.9%
Prophylaxis 3.9%
Diarrhoea 2.7%
Hypertension 2.7%
Chronic Myeloid Leukaemia 2.5%
Multiple Myeloma 2.2%
Epilepsy 2.0%
Angina Pectoris 1.9%
Mitochondrial Toxicity 1.9%
Infection Prophylaxis 1.7%
Plasma Cell Myeloma 1.7%
Ovarian Epithelial Cancer 1.4%
B-cell Lymphoma 1.3%
Hepatic Cirrhosis 1.3%
Oral Candidiasis 1.3%
Pain 1.3%
Myalgia 10.3%
Drug Interaction 7.4%
Myocardial Infarction 7.4%
Sepsis 7.4%
Thrombocytopenia 7.4%
Vomiting 7.4%
Weight Decreased 5.9%
Capillary Leak Syndrome 4.4%
Pancreatic Insufficiency 4.4%
Pyrexia 4.4%
Rash Morbilliform 4.4%
Renal Failure Acute 4.4%
Urticaria 4.4%
Epilepsy 2.9%
Febrile Neutropenia 2.9%
Hyperthyroidism 2.9%
Immune Reconstitution Syndrome 2.9%
Malaise 2.9%
Mucosal Inflammation 2.9%
Overdose 2.9%